SINGAPORE, May 17, 2018 /PRNewswire/ -- Docquity has become the latest addition to Zuellig Pharma's growing digital investment portfolio. The Singapore-based HealthTech startup aims to connect medical professionals globally over a secure digital platform. Its current reach spans 7 countries in Asia with more than 60,000 users and over 1,000 specialized groups.
Through Docquity, doctors are now able to discuss cases through a secure peer-to-peer learning network. Engagement on the platform varies from discussing clinical cases to browsing journals, and includes a reward system that allocates points for contributions. Doctors on the platform can also accrue *CME (Continuing Medical Education) points by participating in educational activities.
This is the first online learning community dedicated to doctors in the region. It functions like a social network and is an invite-only platform that validates users before giving them access. The company is supported by numerous medical associations across the region, who have invited their membership of doctors to join the community.
All materials shared on the platform are indexed, so every time a doctor needs critical information or second opinions, they have instant access to medical peers around the world. The platform also allows doctors to build their reputation by sharing their experience and knowledge with younger doctors who are eager to interact and learn.
"We believe the platform can help our clients in the pharmaceutical industry engage with doctors in meaningful ways. Beyond that, we see the positive impact that Docquity can make on healthcare outcomes and we are keen to accelerate this," said SVP Corporate Development Maarten Kelder.
In 2017, Zuellig Pharma made its first HealthTech investment in Klinify, a digital medical assistant that helps doctors manage their patients seamlessly. "We see the immense value that passionate and driven entrepreneurs can bring to the table. Both Klinify and Docquity are great examples of this. We are constantly impressed by their commitment to improve access to high quality healthcare, which is very much in line with our purpose," Maarten said.
CEO and Co-Founder of Docquity, Indranil Roychowdhury, comments "Our network is growing and generating trusted clinical knowledge every single day, and the engine is learning from this to help doctors make better informed, data-driven decisions. We are extremely excited to partner with Zuellig Pharma, as we see a potent mix of domain expertise, market understanding and technology coming together to help doctors through continual learning."
* all doctors are required to obtain a minimum number of points to renew their practising certificate.
About Zuellig Pharma
Zuellig Pharma is one of the largest healthcare services group in Asia. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started almost a hundred years ago and has grown to become a US$10 billion business covering 13 markets in Asia with over 10,000 employees.
Our purpose is to make healthcare more accessible. Our people serve over 320,000 medical facilities in Asia and we work with over 1000 clients including the top 10 pharmaceutical companies in the world.
More recently, we launched our Zuellig Health Solutions Innovation centre to develop new services and address some pressing healthcare needs in Asia. Since then, our teams have been focused on creating data, digital and disease management solutions, supporting patients with chronic conditions and helping payors manage healthcare costs. We are also making headway in using big data to inform our decisions and those of our clients, on how to optimise for greater operational accuracy and efficiency.
